Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing; Correction, 23499 [2016-09265]
Download as PDF
<![CDATA[
23499
Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices
Background and Brief Description
CDC is requesting OMB approval to
revise information collection for the
Behavioral Risk Factor Surveillance
System (BRFSS). The BRFSS is a
nationwide system of annual, crosssectional telephone health surveys
sponsored by CDC. BRFSS coordinators
in health departments in U.S. states,
territories, and the District of Columbia
(collectively referred to as states)
collaborate with CDC on questionnaire
content and survey administration.
An independent sample of adult, noninstitutionalized respondents is drawn
each for each state and is based on the
state’s parameters for state-level or substate analysis. Each state’s annual
questionnaire is based on a common
core that is administered by all states. In
addition, CDC provides support for
standardized optional modules that
states can use to collect customized
content. Information collection is
conducted in a continuous, three-part
telephone interview process: Screening,
participation in core BRFSS questions,
and participation in the optional
question modules. Both the core survey
and the optional modules are updated
annually.
CDC requests OMB approval to
incorporate a limited annual field test
into the BRFSS clearance. Field testing
will be conducted approximately 5–8
months in advance of the principal
BRFSS survey. Field tests are used to
identify problems with new or updated
questions, instrument documentation or
instructions, software errors, or other
implementation issues. Field tests are
typically conducted in one state.
Addition of the annual field test will
increase the estimated annualized
number of responses by 900 and the
estimated annualized burden by 382
hours. These estimates include
allocations for both respondent
screening and completion of the field
test survey. Each year CDC will use the
Change Request mechanism to request
OMB approval of the annual Field Test
Supplement.
CDC and the states will continue to
use BRFSS data to produce state-level
information about adults 18 years and
older. BRFSS topics include health risk
behaviors, health conditions, and
preventive health practices that are
associated with chronic diseases,
infectious diseases, and injury. This
information is used by state and local
health departments to plan and evaluate
public health programs at the state or
sub-state level. In addition, CDC makes
annual BRFSS data sets available for
public use and provides guidance on
statistically appropriate uses of the data.
Field test results will not be
incorporated into the analytic data sets.
Field test results are used exclusively to
inform the development of the
upcoming year’s BRFSS questionnaire
and the technical assistance that CDC
provides to states.
OMB approval is requested for three
years. Participation in the BRFSS is
voluntary and there are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 256,297.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
U.S. General Population .................................
Landline Screener ..........................................
Cell Phone Screener ......................................
Field Test Screener ........................................
Core Survey ...................................................
Optional Modules ...........................................
Field Test Survey ...........................................
Adults ≥18 Years ............................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–09189 Filed 4–20–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
jstallworth on DSK7TPTVN1PROD with NOTICES
[Docket No. FDA–2016–N–0832]
FOR FURTHER INFORMATION CONTACT:
Phibro Animal Health Corp.; Carbadox
in Medicated Swine Feed; Opportunity
for Hearing; Correction
AGENCY:
Food and Drug Administration,
HHS.
Notice of opportunity for
hearing; correction.
ACTION:
The Food and Drug
Administration (FDA) is correcting a
SUMMARY:
VerDate Sep<11>2014
13:27 Apr 20, 2016
Jkt 238001
notice that appeared in the Federal
Register on April 12, 2016 (81 FR
21559). The document announced an
opportunity for a hearing on FDA’s
Center for Veterinary Medicine’s
proposal to withdraw approval of all
new animal drug applications providing
for use of carbadox in medicated swine
feed and contained an incorrect
telephone number for the individual to
be contacted for further information.
The address for Phibro Animal Health
Corp. was also incorrect. This document
corrects those errors.
Vernon Toelle, Center for Veterinary
Medicine (HFV–234), 7519 Standish Pl.,
Rockville, MD 20855, 240–402–7001.
In FR Doc.
2016–08327, appearing on page 21559
in the Federal Register of Tuesday,
April 12, 2016, the following corrections
are made:
1. On page 21560, in the second
column, in the FOR FURTHER
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00044
Fmt 4703
Sfmt 9990
Number of
responses per
respondent
440,486
223,334
400
494,650
484,757
500
Average
burden per
response
(in hr)
1
1
1
1
1
1
1/60
1/60
1/60
15/60
15/60
45/60
paragraph, the
telephone number is corrected to read
‘‘240–402–7001’’.
2. On page 21560, in the third
column, in the first paragraph, the
address for Phibro Animal Health Corp.
is corrected to read ‘‘GlenPointe Centre
East, 3d floor, 300 Frank W. Burr Blvd.,
suite 21, Teaneck, NJ 07666’’.
3. On page 21572, in the first column,
in the third paragraph, the address for
Phibro Animal Health Corp. is corrected
to read ‘‘GlenPointe Centre East, 3d
floor, 300 Frank W. Burr Blvd., suite 21,
Teaneck, NJ 07666’’.
INFORMATION CONTACT
Dated: April 18, 2016.
Tracey Forfa,
Acting Director, Center for Veterinary
Medicine.
[FR Doc. 2016–09265 Filed 4–20–16; 8:45 am]
BILLING CODE 4164–01–P
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 81, Number 77 (Thursday, April 21, 2016)]
[Notices]
[Page 23499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09265]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2016-N-0832]
Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;
Opportunity for Hearing; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of opportunity for hearing; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
that appeared in the Federal Register on April 12, 2016 (81 FR 21559).
The document announced an opportunity for a hearing on FDA's Center for
Veterinary Medicine's proposal to withdraw approval of all new animal
drug applications providing for use of carbadox in medicated swine feed
and contained an incorrect telephone number for the individual to be
contacted for further information. The address for Phibro Animal Health
Corp. was also incorrect. This document corrects those errors.
FOR FURTHER INFORMATION CONTACT: Vernon Toelle, Center for Veterinary
Medicine (HFV-234), 7519 Standish Pl., Rockville, MD 20855, 240-402-
7001.
SUPPLEMENTARY INFORMATION: In FR Doc. 2016-08327, appearing on page
21559 in the Federal Register of Tuesday, April 12, 2016, the following
corrections are made:
1. On page 21560, in the second column, in the FOR FURTHER
INFORMATION CONTACT paragraph, the telephone number is corrected to
read ``240-402-7001''.
2. On page 21560, in the third column, in the first paragraph, the
address for Phibro Animal Health Corp. is corrected to read
``GlenPointe Centre East, 3d floor, 300 Frank W. Burr Blvd., suite 21,
Teaneck, NJ 07666''.
3. On page 21572, in the first column, in the third paragraph, the
address for Phibro Animal Health Corp. is corrected to read
``GlenPointe Centre East, 3d floor, 300 Frank W. Burr Blvd., suite 21,
Teaneck, NJ 07666''.
Dated: April 18, 2016.
Tracey Forfa,
Acting Director, Center for Veterinary Medicine.
[FR Doc. 2016-09265 Filed 4-20-16; 8:45 am]
BILLING CODE 4164-01-P
